Therapeutic relevance of an EU-GMP certified Cannabis sativa L. strain in a dual in vivo model of cognitive impairment and chronic neuropathic pain
- DOI
- 10.3389/fphar.2026.1761426
- Published
- 2026-02-20
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1761426,
title = {Therapeutic relevance of an EU-GMP certified Cannabis sativa L. strain in a dual in vivo model of cognitive impairment and chronic neuropathic pain},
author = {Ivona Costachescu and Raluca-Maria Gogu and Gabriela-Dumitrita Stanciu and Carmen Solcan and Loredana Horodincu and Andrei Szilagyi and Vlad-Constantin Craciun and Daniela-Carmen Ababei and Bogdan-Ionel Tamba},
year = {2026},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2026.1761426},
url = {https://doi.org/10.3389/fphar.2026.1761426}
}RIS
TY - JOUR TI - Therapeutic relevance of an EU-GMP certified Cannabis sativa L. strain in a dual in vivo model of cognitive impairment and chronic neuropathic pain AU - Ivona Costachescu AU - Raluca-Maria Gogu AU - Gabriela-Dumitrita Stanciu AU - Carmen Solcan AU - Loredana Horodincu AU - Andrei Szilagyi AU - Vlad-Constantin Craciun AU - Daniela-Carmen Ababei AU - Bogdan-Ionel Tamba PY - 2026 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2026.1761426 UR - https://doi.org/10.3389/fphar.2026.1761426 ER -
APA
Costachescu, I., Gogu, R., Stanciu, G., Solcan, C., Horodincu, L., Szilagyi, A., Craciun, V., Ababei, D., & Tamba, B. (2026). Therapeutic relevance of an EU-GMP certified Cannabis sativa L. strain in a dual in vivo model of cognitive impairment and chronic neuropathic pain. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1761426
Source records
- crossref · retrieved 2026-09-27T11:00:20.070Z